Literature DB >> 18408748

Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program.

Anne M Lachiewicz, Marianne Berwick, Charles L Wiggins, Nancy E Thomas.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18408748     DOI： 10.1038/jid.2008.18

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

1.  Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005.

Authors:  Graça M Dores; Mark M Huycke; Susan S Devesa; Carlos A Garcia
Journal:  J Am Acad Dermatol       Date:  2010-05-05       Impact factor: 11.527

2.  Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure.

Authors:  Thomas B Richards; Christopher J Johnson; Zaria Tatalovich; Myles Cockburn; Melody J Eide; Kevin A Henry; Sue-Min Lai; Sai S Cherala; Youjie Huang; Umed A Ajani
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

Review 3.  The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Authors:  David C Whiteman; William J Pavan; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-08-16       Impact factor: 4.693

4.  Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.

Authors:  Marina Kvaskoff; David C Whiteman; Zhen Z Zhao; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward; David L Duffy
Journal:  Twin Res Hum Genet       Date:  2011-10       Impact factor: 1.587

5.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

6.  BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site.

Authors:  Jürgen Bauer; Petra Büttner; Rajmohan Murali; Ichiro Okamoto; Nicholas A Kolaitis; Maria T Landi; Richard A Scolyer; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2011-04       Impact factor: 4.693

7.  Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.

Authors:  Andrzej Slominski; Blazej Zbytek; Radomir Slominski
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

8.  Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.

Authors:  Catherine M Olsen; Michael S Zens; Therese A Stukel; Carlotta Sacerdote; Yu-Mei Chang; Bruce K Armstrong; Veronique Bataille; Marianne Berwick; J Mark Elwood; Elizabeth A Holly; Connie Kirkpatrick; Thomas Mack; Julia Newton Bishop; Anne Østerlind; Anthony J Swerdlow; Roberto Zanetti; Adèle C Green; Margaret R Karagas; David C Whiteman
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

9.  Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011).

Authors:  Julie S Najita; Susan M Swetter; Alan C Geller; Jeffrey E Gershenwald; Marvin Zelen; Sandra J Lee
Journal:  J Invest Dermatol       Date:  2016-05-29       Impact factor: 8.551

10.  Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.

Authors:  Eunjung Kim; Vito Rebecca; Inna V Fedorenko; Jane L Messina; Rahel Mathew; Silvya S Maria-Engler; David Basanta; Keiran S M Smalley; Alexander R A Anderson
Journal:  Cancer Res       Date:  2013-09-30       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.